Mahdiyeh Khanbagi

Journal Articles

Karimi H, Marefat H, Khanbagi M, Kalafatis C, Modarres H, Vahabi Z, Khaligh-Razavi SM Temporal Dynamics of Animacy Categorization in the brain of Patients with Mild Cognitive Impairment. | PLoS ONE (2021)

Kalafatis C, Modarres H, Apostolou P, Marefat H, Khanbagi M, Karimi H, Vahabi Z, Aarsland D, Khaligh-Razavi SM Validity and Cultural Generalizability of a 5-min AI-based, Computerized Cognitive Assessment in Mild Cognitive Impairment and Alzheimer’s Dementia | Frontiers in Psychiatry - Aging Psychiatry (2021)

Karimi H, Marefat H, Khanbagi M, Karami A, Vahabi Z, Drift Diffusion Model Can Detect Patients with Cognitive Impairment, Frontiers in Biomedical Technologies (2020)

Khaligh-Razavi SM, Sadeghi M, Khanbagi M, Kalafatis C, Nabavi SM. A Self-Administered Artificial Intelligence Platform for Cognitive Assessment in Multiple Sclerosis (MS) | BMC Neurol. 20, 193 (2020)

Khaligh-Razavi S-M, Habibi S, Sadeghi M, Marefat H, Khanbagi M, Nabavi SM, et al. Integrated Cognitive Assessment: Speed and Accuracy of Visual Processing as a Reliable Proxy to Cognitive Performance. | Sci Rep. 9, 1102 (2019)

Conference Abstracts

Marefat H, Ebrahiminia F, Khanbagi M, Karimi H, Modarres H, Kalafatis C, Khaligh-Razavi SM How Animacy Processing is Affected in Early Stages of AD?, Alzheimer Association Annual Conference | AAIC (2021)

Aghaei M, Modarres H, Vahabi Z, Kalafatis C, Marefat H, Khanbagi M, sKarimi H, Khaligh- Razavi SM Association between a Computerized, Self-administered Cognitive Assessment and Fluid Biomarkers of Neurodegeneration, Clinical Trials on Alzheimer’s Disease Conference | CTAD (2021)

Khanbagi M, Marefat H, Karimi H, Kalafatis C, Vahabi Z, Khaligh-Razavi SM Association between Integrated Cognitive Assessment (ICA) and Measures of Brain Structure in Mild Cognitive Impairment and Mild Alzheimer’s Disease, Alzheimer Association Annual Conference | AAIC (2020)

Karimi H, Marefat H, Khanbagi M, Kalafatis C, Vahabi Z, Khaligh-Razavi SM Electroencephalography (EEG) reveals a decrease in speed of animacy processing in mild cognitive impairment and an alteration in neural response patterns, Alzheimer Association Annual Conference | AAIC (2020)

Kalafatis C, Modarres MH, Marefat H, Khanbagi M, Karimi H, Vahabi Z, Khaligh-Razavi SM Employing Artificial Intelligence in the Development of a Self-Administered, Computerized Cognitive Assessment for the Assessment of Neurodegeneration, Alzheimer’s & Dementia | Alzheimer’s & Dementia (July 2019)

Marefat H, Karimi H, Khanbagi M, Kalafatis C, Vahabi Z, Khaligh-Razavi SM Neural Speed of Visual Information Processing is Delayed in Early Stages of Alzheimer’s Disease. Alzheimer’s Society Annual Conference | ASAC (2019)

Khaligh-Razavi SM, Modarres H, Marefat H, Karimi H, Khanbagi M, Kalafatis C, Vahabi Z Artificial Intelligence (AI)-Based Cognitive Assessment Tool for Early Diagnosis of AD. Alzheimer’s Research UK | ARUK (2019)

Karimi H, Marefat H, Khanbagi M, Vahabi Z, Khaligh-Razavi SM, Task-based EEG for Detection of Patients with Mild Cognitive Impairment, The 3rd Iranian Symposium on Brain Mapping Updates | ISBM (2019)

Khaligh-Razavi SM, Sadeghi M, Khanbagi M, Kalafatis C, Nabavi SM Using ICA —an artificial intelligence (AI)-assisted technology— as a digital biomarker of MS disease progression and treatment efficacy. 35th Congress of the European Committee for Treatment and Research in Multiple Sclerosis | ECTRIMS (2019)

Sadeghi M, Daemi M, Khaligh-Razavi SM, Tabasi SM, Khanbagi M, Nabavi SM, Kordi MR Virtual Reality(VR)-Based Cognitive Rehabilitation: Cognitive games are complementary to physical training for an optimum rehabilitation strategy in patients with Multiple Sclerosis (MS) | 35th Congress of the European Committee for Treatment and Research in Multiple Sclerosis- ECTRIMS (2019), Oral Presentation

Khaligh-Razavi SM, Sadeghi M, Khanbagi M, Kalafatis C, Nabavi SM A Brief Language- Independent and Self-Administered Computerized Test for Cognitive Assessment in Multiple Sclerosis (MS) |34th Congress of the European Committee for Treatment and Research in Multiple Sclerosis- ECTRIMS (2018)